(R)-3-Boc-4-isopropyl-2,2-dioxo-[1,2,3]oxathiazolidine, 97%, 10g

4-Hydroxy-3,5-dimethylbenzaldehyde, 97.0%, 500g

METHYL 6-BROMO-4-CHLORONICOTINATE, 95.0%, 10g

3-(4-Fluorobenzyloxy)benzaldehyde, 97.0%, 5g

2-(4-(Benzyloxy)-3-methoxyphenyl)acetic acid, 98%, 1g

Acido 6-amminoesanoico, minimo 99%, per sintesi, 500 g, confezione in plastica.

2-AMINO-2-METHYLSUCCINIC ACID, 95%, 250mg

methyl 5-{[(2S)-2-{[(tert-butoxy)carbonyl]amino}-3-(4-carbamoyl-2,6-dimethylphenyl)-N-[(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]propanamido]methyl}-2-methoxybenzoate, 98%, 50mg

6-(2-aminophenyl)-3-methyl-7H-[1,3]thiazolo[3,2-b][1,2,4]triazin-7-one, 95.0%, 1g

2-Propenamide, 3-phenyl-N-[2,2,2-trichloro-1-[[[(4-chlorophenyl)amino]thioxomethyl]amino]ethyl]-, (2E)-, 5mg

2-(4-Hexyloxybenzoyl)-3-methylpyridine, 97.0%, 1g

1-Phenyl-1,3-diazinane-2,4-dione, 97%, 500mg

Dimethyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-2,6-dicarboxylate, 95.0%, 250mg